NHS to trial AI tool for prostate cancer diagnosis
Technology
The NHS is set to test a new AI tool called ArteraAI Prostate Biopsy Assay to help diagnose prostate cancer faster and more accurately.
Backed by a £1.9 million study led by the University of Oxford and Prostate Cancer UK, the project will use biopsies from more than 4,000 men across three years.
The AI scans biopsy images and gives doctors risk scores
This AI scans biopsy images and gives doctors risk scores, which could mean quicker diagnoses and smarter treatment plans for patients.
The trial is happening at several major hospitals, with hopes it'll shorten the wait from diagnosis to treatment.
If all goes well, this tech could become standard across the NHS—helping patients get only the care they really need.